The stock of Acurx Pharmaceuticals Inc (ACXP) has seen a -3.23% decrease in the past week, with a -30.50% drop in the past month, and a -60.18% decrease in the past quarter. The volatility ratio for the week is 12.31%, and the volatility levels for the past 30 days are at 9.71% for ACXP. The simple moving average for the past 20 days is -10.33% for ACXP’s stock, with a -38.16% simple moving average for the past 200 days.
Is It Worth Investing in Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Right Now?
The 36-month beta value for ACXP is also noteworthy at -1.68. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ACXP is 12.06M, and at present, short sellers hold a 2.80% of that float. The average trading volume of ACXP on April 18, 2024 was 160.04K shares.
ACXP) stock’s latest price update
The stock price of Acurx Pharmaceuticals Inc (NASDAQ: ACXP) has jumped by 8.43 compared to previous close of 1.66. Despite this, the company has seen a fall of -3.23% in its stock price over the last five trading days. Seeking Alpha reported 2024-03-18 that Acurx Pharmaceuticals, Inc. (ACXP) Q4 2023 Earnings Call Transcript
ACXP Trading at -30.30% from the 50-Day Moving Average
After a stumble in the market that brought ACXP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.59% of loss for the given period.
Volatility was left at 9.71%, however, over the last 30 days, the volatility rate increased by 12.31%, as shares sank -14.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -42.68% lower at present.
During the last 5 trading sessions, ACXP fell by -3.23%, which changed the moving average for the period of 200-days by -32.08% in comparison to the 20-day moving average, which settled at $1.9918. In addition, Acurx Pharmaceuticals Inc saw -53.00% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ACXP
The total capital return value is set at -740.65. Equity return is now at value -243.33, with -170.64 for asset returns.
Currently, EBITDA for the company is -14.58 million with net debt to EBITDA at 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.53.
Conclusion
In summary, Acurx Pharmaceuticals Inc (ACXP) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
